A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis

Gene

Volumn 537, Issue 2, 2014, Pages 238-244

  Wei, Zhong Hua ^a   Guo, Wen Huan ^a   Wu, Jun ^a   Suo, Wen Hao ^a   Fu, Guo Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastric cancer; Mutation; SNP; Ubiquitination; XPF

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GENOMIC DNA; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; COMET ASSAY; DNA REPAIR; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; UBIQUITINATION; XERODERMA PIGMENTOSUM;

BASE EXCISION REPAIR; BER; ERCC1; EXCISION REPAIR CROSS-COMPLIMENTARY GROUP 1; GASTRIC CANCER; METHYLENETETRAHYDROFOLATE REDUCTASE; MISMATCH REPAIR; MMR; MTHFR; MUTATION; NER; NUCLEOTIDE EXCISION REPAIR; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; UBIQUITINATION; XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP F; XPF;

ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE, TUMOR; CODON, NONSENSE; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; UBIQUITIN;

EID: 84893654893     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.12.061     Document Type: Article

References (45)

1. Abnet C.C., et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 2010, 42(9):764-767.
2. Arora S., et al. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) 2010, 9(7):745-753.
3. Beckman R.A., Loeb L.A. Genetic instability in cancer: theory and experiment. Semin. Cancer Biol. 2005, 15(6):423-435.
4. Bevan S., Houlston R.S. Genetic predisposition to gastric cancer. QJM 1999, 92(1):5-10.
5. Choi Y.J., et al. Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J. Biol. Chem. 2005, 280(31):28644-28652.
6. Chun N., Ford J.M. Genetic testing by cancer site: stomach. Cancer J. 2012, 18(4):355-363.
7. Ciccia A., McDonald N., West S.C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 2008, 77:259-287.
8. de Laat W.L., Jaspers N.G., Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 1999, 13(7):768-785.
9. Diderich K., Alanazi M., Hoeijmakers J.H. Premature aging and cancer in nucleotide excision repair-disorders. DNA Repair (Amst) 2011, 10(7):772-780.
10. Dip R., Camenisch U., Naegeli H. Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair. DNA Repair (Amst) 2004, 3(11):1409-1423.
11. Facista A., et al. Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr. 2012, 3(1):3.
12. Fagbemi A.F., Orelli B., Scharer O.D. Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair (Amst) 2011, 10(7):722-729.
13. Figueiredo C., et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002, 94(22):1680-1687.
14. Fitzgerald R.C., et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J. Med. Genet. 2010, 47(7):436-444.
15. Fortini P., et al. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 2003, 85(11):1053-1071.
16. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 2001, 1(1):22-33.
17. Gregg S.Q., Robinson A.R., Niedernhofer L.J. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease. DNA Repair (Amst) 2011, 10(7):781-791.
18. He J., et al. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an Eastern Chinese population. PLoS One 2012, 7(11):e49308.
19. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411(6835):366-374.
20. Hu Z., Ajani J.A., Wei Q. Molecular epidemiology of gastric cancer: current status and future prospects. Gastrointest. Cancer Res. 2007, 1(1):12-19.
21. Hyka-Nouspikel N., et al. Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells. Stem Cells 2012, 30(9):1901-1910.
22. Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7(5):335-346.
23. Kirschner K., Melton D.W. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Anticancer Res. 2010, 30(9):3223-3232.
24. Klarer A.C., McGregor W. Replication of damaged genomes. Crit. Rev. Eukaryot. Gene Expr. 2011, 21(4):323-336.
25. Knudson A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 2001, 1(2):157-162.
26. Krokan H.E., et al. Base excision repair of DNA in mammalian cells. FEBS Lett. 2000, 476(1-2):73-77.
27. Lagerwerf S., et al. DNA damage response and transcription. DNA Repair (Amst) 2011, 10(7):743-750.
28. Lopez-Lazaro M. A new view of carcinogenesis and an alternative approach to cancer therapy. Mol. Med. 2010, 16(3-4):144-153.
29. Masuyama M., et al. Resonance assignments for the DNA binding domain of ERCC-1/XPF heterodimer. J. Biomol. NMR 2005, 32(2):175.
30. Matoka D.J., et al. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model. Prostate 2012, 72(11):1214-1222.
31. NCBI Reference SNP (refSNP) Cluter Reports: rs2020959 01-29 Available from:. http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgirs=2020959.
32. Rahn J.J., Adair G.M., Nairn R.S. Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair. Environ. Mol. Mutagen. 2010, 51(6):567-581.
33. Reddy M.C., Vasquez K.M. Repair of genome destabilizing lesions. Radiat. Res. 2005, 164(4 Pt 1):345-356.
34. Suzumura H., Arisaka O. Cerebro-oculo-facio-skeletal syndrome. Adv. Exp. Med. Biol. 2010, 685:210-214.
35. Thye T., et al. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am. J. Hum. Genet. 2003, 72(2):448-453.
36. Tripsianes K., et al. The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair. Structure 2005, 13(12):1849-1858.
37. Usanova S., et al. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression. Mol. Cancer 2010, 9:248.
38. Vineis P., et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst. 2009, 101(1):24-36.
39. Volker M., et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell 2001, 8(1):213-224.
40. Wang M., et al. A novel XPF-357A>C polymorphism predicts risk and recurrence of bladder cancer. Oncogene 2010, 29(13):1920-1928.
41. Wood R.D., Burki H.J. Repair capability and the cellular age response for killing and mutation induction after UV. Mutat. Res. 1982, 95(2-3):505-514.
42. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science 2001, 291(5507):1284-1289.
43. Woods C.G. DNA repair disorders. Arch. Dis. Child. 1998, 78(2):178-184.
44. Yeh J.I., et al. Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatinized DNA repair. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(41):E2737-E2746.
45. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J. Hum. Genet. 2006, 51(7):618-624.